135 related articles for article (PubMed ID: 38410076)
1. Complexity of Translating Analytics to Recent Cannabis Use and Impairment.
DeGregorio MW; Kao CJ; Wurz GT
J AOAC Int; 2024 May; 107(3):493-505. PubMed ID: 38410076
[TBL] [Abstract][Full Text] [Related]
2. Direct Quantitation of Phytocannabinoids by One-Dimensional
Dadiotis E; Mitsis V; Melliou E; Magiatis P
Molecules; 2022 May; 27(9):. PubMed ID: 35566314
[TBL] [Abstract][Full Text] [Related]
3. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
4. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
5. Interpretation of Cannabis Findings in the Hair of Very Young Children: Mission Impossible.
Kintz P; Ameline A; Eibel A; Gheddar L; Feisthauer E; Geraut A; Berthelon L; Farrugia A; Raul JS
Curr Pharm Biotechnol; 2017; 18(10):791-795. PubMed ID: 29189142
[TBL] [Abstract][Full Text] [Related]
6. 11-Nor-9-Carboxy-Δ8-Tetrahydrocannabinol, 7-Carboxy Cannabidiol, and 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Urine by LC-MS/MS.
Hughs ML; McMillin GA
Methods Mol Biol; 2024; 2737():161-174. PubMed ID: 38036820
[TBL] [Abstract][Full Text] [Related]
7. Recent challenges and trends in forensic analysis: Δ9-THC isomers pharmacology, toxicology and analysis.
La Maida N; Di Giorgi A; Pichini S; Busardò FP; Huestis MA
J Pharm Biomed Anal; 2022 Oct; 220():114987. PubMed ID: 35985136
[TBL] [Abstract][Full Text] [Related]
8. THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".
Pacifici R; Pichini S; Pellegrini M; Rotolo MC; Giorgetti R; Tagliabracci A; Busardò FP; Huestis MA
Clin Chem Lab Med; 2020 Apr; 58(5):682-689. PubMed ID: 30956228
[TBL] [Abstract][Full Text] [Related]
9. Occupational Exposure to Secondhand Cannabis Smoke Among Law Enforcement Officers Providing Security at Outdoor Concert Events.
Wiegand DM; Methner MM; Grimes GR; Couch JR; Wang L; Zhang L; Blount BC
Ann Work Expo Health; 2020 Aug; 64(7):705-714. PubMed ID: 32219297
[TBL] [Abstract][Full Text] [Related]
10. Analysis of homemade cannabis edibles by UHPLC-HRMS after standard addition method.
Thiebot P; Magny R; Langrand J; Dufayet L; Houze P; Labat L
J Anal Toxicol; 2024 Jun; 48(5):372-379. PubMed ID: 38407251
[TBL] [Abstract][Full Text] [Related]
11. The failings of
Arkell TR; Spindle TR; Kevin RC; Vandrey R; McGregor IS
Traffic Inj Prev; 2021; 22(2):102-107. PubMed ID: 33544004
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of five distinct commercially available hemp-derived topical cannabidiol products.
Zamarripa CA; Tilton HE; Lin S; Cone EJ; Winecker RE; Flegel RR; Kuntz D; Beals M; Jacques M; Clark M; Welsh ER; Wagner L; Bonn-Miller MO; Vandrey R; Spindle TR
J Anal Toxicol; 2024 Mar; 48(2):81-98. PubMed ID: 38217086
[TBL] [Abstract][Full Text] [Related]
13. Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath.
Hubbard JA; Smith BE; Sobolesky PM; Kim S; Hoffman MA; Stone J; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
Clin Chem Lab Med; 2020 Apr; 58(5):673-681. PubMed ID: 31527291
[TBL] [Abstract][Full Text] [Related]
14. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
[TBL] [Abstract][Full Text] [Related]
15. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol.
Bergeria CL; Strickland JC; Spindle TR; Kalaba M; Satyavolu PU; Feldner M; Vandrey R; Bonn-Miller M; Peters EN; Weerts E
Exp Clin Psychopharmacol; 2023 Apr; 31(2):312-317. PubMed ID: 35467921
[TBL] [Abstract][Full Text] [Related]
16. Orally administered cannabidiol does not produce false-positive tests for Δ
McCartney D; Kevin RC; Suraev AS; Irwin C; Grunstein RR; Hoyos CM; McGregor IS
Drug Test Anal; 2022 Jan; 14(1):137-143. PubMed ID: 34412166
[TBL] [Abstract][Full Text] [Related]
17. Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use.
Pichini S; Mannocchi G; Berretta P; Zaami S; Pirani F; Pacifici R; Busardò FP
Ther Drug Monit; 2020 Feb; 42(1):151-156. PubMed ID: 31389860
[TBL] [Abstract][Full Text] [Related]
18. Indeterminacy of cannabis impairment and ∆
Wurz GT; DeGregorio MW
Sci Rep; 2022 May; 12(1):8323. PubMed ID: 35585089
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the impact of hemp food consumption on workplace drug tests.
Leson G; Pless P; Grotenhermen F; Kalant H; ElSohly MA
J Anal Toxicol; 2001; 25(8):691-8. PubMed ID: 11765026
[TBL] [Abstract][Full Text] [Related]
20. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
Niesink RJ; Rigter S; Koeter MW; Brunt TM
Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
